hs-CRP Explained for UK Patients

Medically reviewed by Hemal Patel, PhD, Professor of Anesthesiology at UC San Diego School of Medicine. UCSD profile.

Written by Hemal Patel, PhD, Head Science Advisor at MeScreen UK. Clinically reviewed by Toby Moeller, MD, Chief Science Officer.

hs-CRP attracts two unhelpful reactions. One is to ignore it because it sounds vague. The other is to treat it as a secret portal into ageing, cardiovascular risk and chronic disease. Both are excessive.

Used properly, high-sensitivity C-reactive protein is a practical marker of low-grade systemic inflammation. It does not diagnose a specific disease, but it can show whether the body seems to be carrying more inflammatory burden than expected when read alongside lipids, glucose markers, blood pressure, symptoms and body composition.^[1][2]

For UK patients, that is where the test becomes useful. The NHS is focused on diagnosis, treatment and evidence-based screening at scale. Private preventative testing adds value only when it gives more detail about trend and risk, rather than trying to replace standard medical care.

1. What hs-CRP actually measures

CRP is a protein made largely by the liver in response to inflammatory signalling, particularly interleukin-6. A standard CRP test is often used when infection or significant inflammation is suspected. The high-sensitivity version detects much lower concentrations, so it can pick up low-grade inflammation that might not appear on a routine CRP test.^[1][3]

That sensitivity is why hs-CRP is discussed in cardiometabolic prevention. Persistent low-grade inflammation appears to contribute to atherosclerosis and is associated with cardiovascular risk.^[4] Still, hs-CRP is not a verdict. It is a clue.

2. Why clinicians pay attention to it

The most established preventative use of hs-CRP is in cardiovascular risk refinement. Two people can have similar cholesterol numbers and blood pressure, yet different inflammatory burden. In some cases, hs-CRP helps explain why one risk profile looks more concerning than it first appears. Studies such as JUPITER helped move this into mainstream preventive cardiology.^[5]

That does not mean everyone in Britain needs serial hs-CRP testing. It means the marker can be useful when there is a sensible question behind it, for example in family-history risk review, broader prevention panels, or repeat testing after lifestyle change. Our guide to what cellular health tests actually measure explains how these biomarker panels fit together.

3. What can make hs-CRP go up

hs-CRP is non-specific. A raised result may reflect low-grade cardiometabolic inflammation, but it can also rise because of a recent cold, a dental infection, hard training, poor sleep, obesity, smoking, autoimmune disease, inflammatory arthritis, and other causes.^[1][2]

That is why interpretation depends on timing and context. If you had flu-like symptoms last week, a hard event at the weekend, and poor sleep before the blood draw, your result may be far less profound than it looks. If hs-CRP is persistently raised across repeat tests and the rest of the profile points the same way, the finding becomes more persuasive.

Never let a single inflammatory marker audition for the role of diagnosis. That part belongs to clinical history, examination and, if needed, proper medical assessment.

4. How to think about the numbers

In cardiovascular prevention, hs-CRP is often discussed in broad bands: below 1 mg/L is generally considered lower risk, 1 to 3 mg/L average risk, and above 3 mg/L higher risk, assuming there is no acute infection or obvious inflammatory illness at the time of testing.^[1][3] These are useful shortcuts, not magical boundaries.

Results above about 10 mg/L usually deserve extra caution before interpretation, because that level may indicate an acute process rather than the low-grade inflammation relevant to long-term prevention. In that situation, the sensible move is often to repeat the test once the transient issue has passed.

The most useful question is not “Is this number perfect?” but “Does this number make sense alongside everything else?” If hs-CRP is mildly raised, ApoB is high, waist circumference is creeping up, sleep is poor and HbA1c is drifting, then the pattern is coherent.

5. Where the NHS fits, and where private testing adds detail

The NHS does not exist to provide every advanced biomarker on demand, and that is not a criticism. Public systems have to prioritise interventions with clear population-scale value. Preventative interest, by contrast, is often more individual. People want baseline data, trend tracking, and a better sense of where friction may be developing before it becomes diagnostic disease.

That is where private testing can be reasonable. It should fill information gaps, not encourage fantasies of total control. A good provider will explain what the marker can and cannot do, tell you when repeat testing makes sense, and be clear that abnormal results may warrant review with your GP or another qualified clinician. Our article on preventative tests the NHS does not routinely offer covers that gap in more detail.

6. What may help lower hs-CRP over time

If a raised hs-CRP reflects genuine low-grade inflammatory burden rather than a temporary illness, the interventions are reassuringly familiar. Weight loss, if clinically appropriate, is one of the most reliable ways to reduce CRP. Smoking cessation matters. Regular physical activity helps, as do better sleep, improved glycaemic control and treatment of underlying periodontal or inflammatory conditions.^[2][6][7]

Diet matters too, though usually through patterns rather than miracle ingredients. A diet rich in minimally processed foods, fibre, unsaturated fats and adequate protein is more convincing than an anti-inflammatory supplement stack assembled in a mood of financial recklessness.

If you are using testing properly, the point is to create a before-and-after comparison grounded in actual change. That is why the MeScreen test process focuses on results you can revisit and discuss.

7. When hs-CRP is useful, and when it is mostly noise

hs-CRP is useful when it answers a real question. It is useful when interpreted with ApoB, HbA1c, blood pressure, symptoms, family history and lifestyle context. It is useful when repeated after a reasonable interval to see whether a pattern holds.

It is much less useful when treated as a standalone morality score. Sensible interpretation is dull, but dull is often where the value lives.

Frequently asked questions

References

1. Ridker PM. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice. Curr Cardiol Rep. 2003;5(5):341-348. doi:10.1007/s11886-003-0088-1.
2. Sproston NR, Ashworth JJ. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front Immunol. 2018;9:754. doi:10.3389/fimmu.2018.00754.
3. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. Circulation. 2003;107(3):499-511. doi:10.1161/01.CIR.0000052939.59093.45.
4. Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868-874. doi:10.1038/nature01323.
5. Ridker PM, Danielson E, Fonseca FAH, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195-2207. doi:10.1056/NEJMoa0807646.
6. Ford ES. Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology. 2002;13(5):561-568. doi:10.1097/00001648-200209000-00013.
7. Esser N, Paquot N, Scheen AJ. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease. Expert Opin Investig Drugs. 2015;24(3):283-307. doi:10.1517/13543784.2015.974804.